Category Archives: The IPO Buzz

By: John E. Fitzgibbon, Jr.

A rainbow will stretch over lower Manhattan this week as Wall Street’s bankers get ready to price two big IPOs, with the aim of raising $8.6 billion. If things go according to plan, there might be a pot or two of gold in the offing.

 

By: John E. Fitzgibbon, Jr.

The thrill of victory and the agony of defeat made themselves known in last week’s IPO market. One deal soared in the aftermarket while another crashed on take-off. Both left everyone shaking their heads.

 

By: John E. Fitzgibbon, Jr.

GAME, Shanda Games’ proposed trading symbol, will be the lightning rod to this week’s IPO calendar. That’s nice to know, but the calendar needs a supporting cast to sustain any kind of momentum. It has it. Some experts have said to expect a rebirth of the IPO market in 2010. You don’t have to wait that long — it’s arrived.

 

By: John E. Fitzgibbon, Jr.

Fashion Week’s curtain went up in New York City last Thursday with all the sparkle and glitter one can imagine. Not to be outdone, Wall Street started parading IPOs down its runway. Companies began filing S-1/A amendments setting proposed pricing terms, and most found their way onto a then-vacant IPO calendar. Wall Street’s fall season is shaping up to be “active.”

 

By: John E. Fitzgibbon, Jr.

If you blinked twice on Friday, you might have missed September’s first IPO.

 

By: John E. Fitzgibbon, Jr.

Found inside every IPO’s prospectus is the sub-title “Lock-up Agreements.” Insiders agree not to sell any of their holdings for a period of normally 180 days. It’s there to discourage the “pump-and-dump” schemes that were popular before the Securities Act of 1933 went into effect. This clause is found in the Rosetta Stone (NYSE: RST) prospectus.

 

The IPO welcome mat gets rolled up this week, but it’s not “due to market conditions.” It’s seasonal. We are moving into the last two weeks of summer. That’s when the new-issue players close shop and head off to exotic places with 5-Star accommodations — or maybe Brighton Beach this year.

 

By: John E. Fitzgibbon, Jr.

When you hear Nashville, the Grand Ole Opry comes to mind. But that’s not the only thriving business in that part of Tennessee. This week’s IPO calendar features two Nashville-based companies with healthcare-related businesses: Cumberland Pharmaceuticals (NASDAQ: CPIX – proposed) and Emdeon (NYSE: EM – proposed).

 

By: John E. Fitzgibbon, Jr.

Investment bankers will reach across the Pacific Ocean this week and bring Wall Street two Asian companies that plan to go public in the United States. The deals are Avago Technologies (NASDAQ: AVGO – proposed) and CDC Software (NASDAQ: CDCS – proposed).

 

By: John E. Fitzgibbon, Jr.

Depending upon which IPO service you follow, you’ll find either two or three deals on this week’s new-issues calendar. Two are newly minted companies while the other has been publicly traded since October 2005.